Age- and sex-related incidence of surgically treated primary hyperparathyroidism

World Journal of Surgery

Volumn 32, Issue 5, 2008, Pages 795-799

  Miller, Barbra S ^a   Dimick, Justin ^a   Wainess, Reid ^a   Burney, Richard E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENDOCRINE SURGERY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; RANDOM SAMPLE; SEX RATIO; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; INCIDENCE; INFANT; MALE; MIDDLE AGED; PARATHYROIDECTOMY; RISK FACTORS; SEX DISTRIBUTION; UNITED STATES;

EID: 42449135676     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9427-2     Document Type: Article

References (15)

1. Heath H III, Hodgson SF, Kennedy M (1980) Primary hyperparathyroidism: incidence, morbidity and potential economic impact in a community. N Engl J Med 302:189-193
2. Melton LJ III (1991) Epidemiology of primary hyperparathyroidism. J Bone Miner Res 6(Suppl 2):S25-S30
3. Wermers RA, Khosla S, Atkinson EJ (1997) The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota 1965-1992. Ann Intern Med 126:433-440
4. Melton LJ III (2002) The epidemiology of primary hyperparathyroidism in North America. J Bone Miner Res 17(Suppl 2):N12-17
5. Wermers RA, Khosla S, Atkinson EJ et al. (2006) Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of disease. J Bone Miner Res 21:171-177
6. Bilezikian JP, Silverberg SJ (2000) The clinical spectrum of primary hyperparathryoidism. Rev Endocr Metab Disord 1:237-245
7. Adami S, Marcocci C, Gatti D (2002) Epidemiology of hyperparathyroidism in Europe. J Bone Miner Res 17-2:N18-23
8. Ljunghall S, Hellman P, Rastad J et al. (1991) Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture. World J Surg 15:681-687
9. Joborn C, Ljunghall S, Larsson K et al. (1991) Skeletal responsiveness to parathyroid hormone in healthy females: relationship to menopause and estrogen replacement. Clin Endocrinol 34:335
10. HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). 2000-2001. Agency for Healthcare Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/nisoverview.jsp
11. Wells G, Tugwell P, Shea B et al. (2002) Metaanalyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev 23:529-539
12. Wong C, Lai T, Hilly JM et al. (2002) Selective estrogen receptor modulators inhibit the effects of insulin-like growth factors in hyperparathyroidism. Surgery 132:998-1006; discussion 1006-1007
13. Kort KC, Schiller HJ, Numann PJ (1999) Hyperparathyroidism and pregnancy. Am J Surg 177:66-68
14. Rastad J, Ekbom A, Hultin H et al. (2001) Childbearing and the risk of parathyroid adenoma-a dominant cause for primary hyperparathyroidism. J Intern Med 250:43-49
15. HCUP State Ambulatory Surgery Databases (SASD). Healthcare Cost and Utilization Project (HCUP). 2000-2004. Agency for Healthcare Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/sasdoverview.jsp